Differences in heroin overdose risk associated with the unregulated drug market: Insights from a supervised injecting facility in Melbourne, Australia
Addiction · 2025
DOI: 10.1111/add.16706 ↗Kurz gefasst
Fachartikel in der Zeitschrift Addiction, 2025. Verfasst von Nathan C Stam und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medically Supervised Injecting Room, North Richmond Community Health, Richmond, Victoria, Australia. Hauptthemen laut MEDLINE: Drug Overdose, Substance Abuse, Intravenous, Heroin Dependence, Heroin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Aims
To determine the contribution that variation in the unregulated drug market has on the risk of heroin overdose across individuals with different levels of personal overdose risk.
Design
A retrospective cohort study of heroin injecting episodes and overdose cases were examined over a 12‐month period between 30 June 2022 and 30 June 2023.
Setting
The Medically Supervised Injecting Room in Melbourne, Australia. Cases 1474 witnessed heroin overdose cases were examined amongst a cohort of 337 individuals who were predominantly male ( n = 276, 81.7%) with a median age of 43.5 years (interquartile range 37.25–49.00 years, range 20–75 years).
Measurements
The daily overdose rate was used to differentiate High and Low daily overdose risk categories. The number of overdose events that an individual experienced during the study period was used to differentiate people into Standard , Moderate and High personal overdose risk categories. Each overdose case was differentiated by the personal overdose risk of the individual who experienced the overdose, as well as the overdose risk of the day that overdose occurred. A stratified overdose risk profile was then derived across the nine different daily overdose risk and personal overdose risk categories.
Findings
The rate of overdose approximately doubled on High overdose risk days compared with Standard overdose risk days, increasing by a factor of 2.11, 2.41 and 2.03 times for individuals in the Standard , Moderate and High personal overdose risk groups. Conversely, the rate of overdose was also substantially reduced on Low overdose risk days to a factor of 0.17, 0.28 and 0.20, respectively.
Conclusion
Among heroin users in Melbourne, Australia, there is an approximately 10‐times difference in the risk of overdose on some days compared with others, which appears to be attributable to the effects of the unregulated drug market and not the effects of variation in personal overdose risk of individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medically Supervised Injecting Room, North Richmond Community Health, Richmond, Victoria, Australia.
- School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
- Monash Addiction Research Centre, Monash University, Melbourne, Australia.
- Department of General Practice and Primary Care, The University of Melbourne, Melbourne, Australia.
- Drug Intelligence Unit, Victorian Institute of Forensic Medicine, Melbourne, Australia.
- Department of Forensic Medicine, Monash University, Melbourne, Australia.
ORCID-Profile: Nathan C Stam, John Furler, Jennifer L Schumann
Zitieren
APA
Stam, N. C., Furler, J., Hiley, S., & Schumann, J. L. (2025). Differences in heroin overdose risk associated with the unregulated drug market: Insights from a supervised injecting facility in Melbourne, Australia. Addiction. https://doi.org/10.1111/add.16706
Vancouver
Stam NC, Furler J, Hiley S, Schumann JL. Differences in heroin overdose risk associated with the unregulated drug market: Insights from a supervised injecting facility in Melbourne, Australia. Addiction. 2025. doi:10.1111/add.16706
BibTeX
@article{Stam2025,
author = {Stam, Nathan C and Furler, John and Hiley, Sarah and Schumann, Jennifer L},
title = {Differences in heroin overdose risk associated with the unregulated drug market: Insights from a supervised injecting facility in Melbourne, Australia},
journal = {Addiction},
year = {2025},
doi = {10.1111/add.16706}
}
EUVIMED